Loading company…
Renke develops genomic and tumor genetic testing products, including pan-cancer screening.
Founded in 2021 and based in Beijing, Renke develops genomics and tumor genetic testing technologies. Its products cover early cancer screening, diagnosis, treatment, and monitoring, including screening for stomach and lung cancers.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in